99-17051. Final Results of Expedited Sunset Review: Aspirin From Turkey  

  • [Federal Register Volume 64, Number 128 (Tuesday, July 6, 1999)]
    [Notices]
    [Pages 36328-36330]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-17051]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF COMMERCE
    
    International Trade Administration
    [A-489-602]
    
    
    Final Results of Expedited Sunset Review: Aspirin From Turkey
    
    AGENCY: Import Administration, International Trade Administration, 
    Department of Commerce.
    
    ACTION: Notice of final results of expedited sunset review: aspirin 
    from Turkey.
    
    -----------------------------------------------------------------------
    
    SUMMARY: On March 1, 1999, the Department of Commerce (``the 
    Department'') initiated a sunset review of the antidumping duty order 
    on aspirin from Turkey (64 FR 9970) pursuant to section 751(c) of the 
    Tariff Act of 1930, as amended (``the Act''). On the basis of a notice 
    of intent to participate and substantive comments filed on behalf of 
    the domestic industry and inadequate response (in this case, no 
    response) from respondent interested parties, the Department determined 
    to conduct an expedited review. As a result of this review, the 
    Department finds that revocation of the antidumping order would be 
    likely to lead to continuation or recurrence of dumping at the levels 
    indicated in the Final Results of Review section of this notice.
    
    FOR FURTHER INFORMATION CONTACT: Scott E. Smith or Melissa G. Skinner, 
    Office of Policy for Import Administration, International Trade 
    Administration, U.S. Department of Commerce, 14th Street and 
    Constitution Avenue, NW, Washington, D.C. 20230; telephone: (202) 482-
    6397 or (202) 482-1560, respectively.
    
    EFFECTIVE DATE: July 6, 1999.
    
    Statute and Regulations
    
        This review was conducted pursuant to sections 751(c) and 752 of 
    the Act. The Department's procedures for the conduct of sunset reviews 
    are set forth in Procedures for Conducting Five-year (``Sunset'') 
    Reviews of Antidumping and Countervailing Duty Orders, 63 FR 13516 
    (March 20, 1998) (``Sunset Regulations''). Guidance on methodological 
    or analytical issues relevant to the Department's conduct of sunset 
    reviews is set forth in the Department's Policy Bulletin 98:3--Policies 
    Regarding the Conduct of Five-year (``Sunset'') Reviews of Antidumping 
    and Countervailing Duty Orders; Policy Bulletin, 63 FR 18871 (April 16, 
    1998) (``Sunset Policy Bulletin'').
    
    Scope
    
        The product covered by this review is acetylsalicylic acid 
    (aspirin) from Turkey, containing no additives, other than inactive 
    substances (such as starch, lactose, cellulose, or coloring material), 
    and/or active substances in concentrations less than that specified for 
    particular non-prescription drug combinations of aspirin and active 
    substances as published in the Handbook of Non-Prescription Drugs, 
    eighth edition, American Pharmaceutical Association, and is not in 
    tablet, capsule, or similar forms for direct human consumption. This 
    product is currently classifiable under the Harmonized Tariff Schedule 
    (``HTS'') of the United States item numbers 2918.22.10 and 3003.90.00. 
    1 The HTS item numbers are provided for convenience and 
    customs purposes only. The written description remains dispositive.
    ---------------------------------------------------------------------------
    
        \1\ In its substantive response, Rhodia noted that the written 
    description of the scope of the order indicated that this product 
    was covered under not only under HTS item number 2918.22.10, but 
    also item number 3003.90.00. The Department agrees. Although this 
    item number has not been previously included in the scope section of 
    prior Department determinations in this case, we confirmed with the 
    U.S. Customs Service that both HTS item numbers were appropriate 
    (see Memo to File; Re: HTS Item Numbers for Aspirin). Therefore, we 
    have included HTS item number 3003.90.00.
    ---------------------------------------------------------------------------
    
    History of the Order
    
        On July 1, 1987, the Department issued a final determination of 
    sales at less than fair value with respect to imports of aspirin 
    (acetylsalicylic acid) from Turkey. 2 The antidumping duty 
    order on aspirin was issued by the Department on August 25, 1987, and, 
    in the order, the dumping margins that were found in the final 
    determination were confirmed. 3 Since the imposition of this 
    order, the Department has conducted one administrative review. 
    4 The order remains in effect for all manufacturers and 
    exporters of the subject merchandise.
    ---------------------------------------------------------------------------
    
        \2\ See Final Determination of Sales at Less Than Fair Value; 
    Acetylsalicylic Acid From Turkey, 52 FR 24492 (July 1, 1987).
        \3\ See Acetylsalicylic Acid From Turkey; Antidumping Duty 
    Order, 52 FR 32030 (August 25, 1987).
        \4\ See Acetylsalicylic Acid From Turkey; Final Results of 
    Antidumping Duty Administrative Review, 63 FR 34146 (June 23, 1998), 
    and Termination of Antidumping Duty Administrative Review; 
    Acetylsalicylic Acid From Turkey, 58 FR 11208 (February 24, 1993).
    ---------------------------------------------------------------------------
    
        This review covers all producers and exporters of aspirin from 
    Turkey.
    
    Background
    
        On March 1, 1999, the Department initiated a sunset review of the 
    antidumping order on aspirin from Turkey (64 FR 9970), pursuant to 
    section 751(c) of the Act. The Department received a Notice of Intent 
    to Participate on behalf of Rhodia on March 15, 1999, within the 
    deadline specified in section 351.218(d)(1)(i) of the Sunset 
    Regulations. We received a complete substantive response from Rhodia on 
    March 31, 1999, within the 30-day deadline specified in the Sunset 
    Regulations in section 351.218(d)(3)(i). Rhodia claimed interested 
    party status under section 771(9)(C) of the Act as a U.S. producer of 
    the domestic like product.
        Additionally, Rhodia stated that it was not a participant in either 
    the original investigation nor the lone administrative review conducted 
    by the Department. However, Rhodia stated that, of the four domestic 
    producers originally involved in the investigation, two--Sterling Drug 
    and Norwich-Eaton --have since ceased production of subject aspirin. 
    The other two producers, Monsanto Chemical Company and Dow Chemical 
    U.S.A., had their aspirin production taken over by Rhone-Poulenc S.A. 
    Rhodia is the subsidiary of Rhone-Poulenc S.A. responsible for bulk 
    aspirin production and is the successor in interest to Monsanto, which 
    was the original petitioner.
        We did not receive a substantive response from any respondent 
    interested party to this proceeding. As a result, pursuant to section 
    351.218(e)(1)(ii)(C) of the Sunset Regulations, the Department 
    determined to conduct an expedited, 120-day, review of this order.
    
    Determination
    
        In accordance with section 751(c)(1) of the Act, the Department 
    conducted this review to determine whether revocation of the 
    antidumping order would be likely to lead to continuation or recurrence 
    of dumping. Section 752(c) of the Act provides that, in making this 
    determination, the
    
    [[Page 36329]]
    
    Department shall consider the weighted-average dumping margins 
    determined in the investigation and subsequent reviews and the volume 
    of imports of the subject merchandise for the period before and the 
    period after the issuance of the antidumping order, and shall provide 
    to the International Trade Commission (``the Commission'') the 
    magnitude of the margin of dumping likely to prevail if the order is 
    revoked.
        The Department's determinations concerning continuation or 
    recurrence of dumping and the magnitude of the margin are discussed 
    below. In addition, Rhodia's comments with respect to continuation or 
    recurrence of dumping and the magnitude of the margin are addressed 
    within the respective sections below.
    
    Continuation or Recurrence of Dumping
    
        Drawing on the guidance provided in the legislative history 
    accompanying the Uruguay Round Agreements Act (``URAA''), specifically 
    the Statement of Administrative Action (``the SAA''), H.R. Doc. No. 
    103-316, vol. 1 (1994), the House Report, H.R. Rep. No. 103-826, pt.1 
    (1994), and the Senate Report, S. Rep. No. 103-412 (1994), the 
    Department issued its Sunset Policy Bulletin providing guidance on 
    methodological and analytical issues, including the bases for 
    likelihood determinations. In its Sunset Policy Bulletin, the 
    Department indicated that determinations of likelihood will be made on 
    an order-wide basis (see section II.A.2). In addition, the Department 
    indicated that normally it will determine that revocation of an 
    antidumping order is likely to lead to continuation or recurrence of 
    dumping when (a) dumping continued at any level above de minimis after 
    the issuance of the order, (b) imports of the subject merchandise 
    ceased after the issuance of the order, or (c) dumping was eliminated 
    after the issuance of the order and import volumes for the subject 
    merchandise declined significantly (see section II.A.3).
        In addition to considering guidance on likelihood cited above, 
    section 751(c)(4)(B) of the Act provides that the Department shall 
    determine that revocation of an order is likely to lead to continuation 
    or recurrence of dumping when a respondent interested party waives its 
    participation in the sunset review. In the instant review, the 
    Department did not receive a response from any respondent interested 
    party. Pursuant to section 351.218(d)(2)(iii) of the Sunset 
    Regulations, this constitutes a waiver of participation.
        In its substantive response, Rhodia argued that revocation of the 
    order will likely lead to continuation or recurrence of dumping of 
    aspirin from Turkey. Rhodia stated that compelling evidence supporting 
    this conclusion includes: (1) The cessation of Turkish imports 
    following the issuance of the order; (2) increased imports of bulk 
    aspirin from other countries; (3) downward pricing pressure resulting 
    from intense competition in the U.S. market from Chinese imports; and 
    (4) continuing interest in the U.S. market by Turkish producers as 
    evidenced by the temporary resumption of Turkish imports in 1997.
        With respect to whether imports of the subject merchandise ceased 
    after the issuance of the order, Rhodia, citing data from the United 
    States Census Bureau, argued that imports of Turkish aspirin declined 
    significantly with the imposition of dumping duties in 1987. 
    Specifically, Rhodia stated that, in 1987, the year immediately 
    following imposition of the order, import volumes from Turkey declined 
    dramatically, decreasing from 1.3 million pounds to just over 200,000 
    pounds. Rhodia stated that imports of aspirin from Turkey continued to 
    decline until they completely ceased in 1990. Further, Turkish imports 
    remained at zero until 1997 when imports rose to just over 5,000 
    pounds. The 1997 shipment, Rhodia argues, was the basis for the sole 
    administrative review of the order, conducted for the 1996-1997 time 
    period. Therefore, Rhodia argues, the decline and cessation of Turkish 
    import volumes of bulk aspirin following the imposition of the 
    antidumping duty order provides a strong indication that, absent an 
    order, dumping would be likely to recur, because the evidence would 
    indicate that the exporter needs to dump to sell at pre-order volumes. 
    (See Substantive Response of Rhodia at 10.)
        Additionally, Rhodia also argues that, because of the nature of the 
    market for bulk aspirin, were Turkish producers to reenter the U.S. 
    market, they would have to dump in order to compete. Rhodia argues that 
    bulk aspirin is a commodity and, as such, competition is based 
    primarily on price. Further, recent imports of bulk aspirin from other 
    countries, most notably China, have increased and, as import volumes 
    have increased, prices have fallen. Therefore, Rhodia argues that the 
    only way that Turkish producers would realistically be able to reenter 
    the U.S. market would be to meet the price competition posed by the low 
    Chinese import prices.
        Consistent with section 752(c) of the Act, the Department has 
    considered whether dumping continued at any level above de minimis 
    after the issuance of the order. In the administrative review covering 
    the 1996-1997 period, the Department determined that no dumping margin 
    existed for Atabay Kimya Sanayi ve Ticaret A.B. (``Atabay'') (63 FR 
    34146, June 23, 1998) and, therefore, a cash deposit rate of zero was 
    imposed for Atabay. Because neither Proces Kimya Sinayi ve Ticaret 
    (``Proces''), one of the two companies examined in the original 
    investigation, nor any other companies, other than Atabay, have been 
    examined in the course of administrative review, the deposit rates for 
    all companies, other than Atabay, continue to be the margins of dumping 
    found in the original investigation--38.60 percent for Proces and 32.98 
    percent for all others. Therefore, we determine that although there was 
    no dumping found for Atabay in the 1997 review period, the same cannot 
    be said for other Turkish producers/exporters.
        Consistent with section 752(c) of the Act, the Department also 
    considered the volume of imports before and after issuance of the 
    order. The import statistics on imports of the subject merchandise from 
    pre-order 1986 to 1998 (as provided by the domestic industry and 
    confirmed by the Department by United States Census Bureau IM146 data) 
    demonstrate that imports of the subject merchandise declined 
    dramatically immediately following the imposition of the order, and 
    continued to decline until 1990 when imports ceased. The only imports 
    of bulk aspirin from Turkey since 1990 involved just over 5,000 pounds 
    in 1997. We agree with Rhodia that imports from Turkey have declined 
    substantially since the imposition of the order in 1987 and, therefore, 
    we determine that, although dumping was eliminated by Atabay, its 
    export volumes have declined significantly since the issuance of the 
    order.
        As set forth in the Sunset Policy Bulletin (section II.A.3), and 
    consistent with the SAA at 889-90 and the House Report at 63, the 
    Department normally will find that revocation of the antidumping duty 
    order likely will lead to continuation or recurrence of dumping when 
    dumping margins continued at any level after the issuance of the order 
    or when dumping was eliminated after the issuance of the order and 
    import volumes of the subject merchandise declined significantly or 
    ceased. With respect to Atabay, although dumping was eliminated in 
    1997, shipments of the subject merchandise have declined dramatically. 
    Further, with respect to all
    
    [[Page 36330]]
    
    other Turkish producers/exporters, antidumping duty deposit rates 
    remain in effect and we have no reason to believe that dumping has been 
    eliminated. On the basis of this analysis, in conjunction with the fact 
    that respondent interested parties have waived their right to 
    participate in this review before the Department, and, absent argument 
    and evidence to the contrary, the Department determines that dumping is 
    likely to continue if the order were revoked.
    
    Magnitude of the Margin
    
        In the Sunset Policy Bulletin, the Department stated that it 
    normally will provide to the Commission the margin that was determined 
    in the final determination in the original investigation. Further, for 
    companies not specifically investigated or for companies that did not 
    begin shipping until after the order was issued, the Department 
    normally will provide a margin based on the ``all others'' rate from 
    the investigation. (See section II.B.1 of the Sunset Policy Bulletin.) 
    Exceptions to this policy include the use of a more recently calculated 
    margin, where appropriate, and consideration of duty absorption 
    determinations. (See sections II.B.2 and 3 of the Sunset Policy 
    Bulletin.)
        The Department, in its final determination of sales at less than 
    fair value, published weighted-average dumping margins for two Turkish 
    producers/exporters of the subject merchandise, Atabay and Proses, and 
    for all other producers/exporters (52 FR 24492, July 1, 1987). The 
    margins calculated in that determination were 27.35 percent for Atabay, 
    38.60 percent for Proses, and an ``all others'' rate of 32.98 percent. 
    Atabay, as mentioned above, received a zero margin during the sole 
    administrative review for the 1996-1997 review period (63 FR 34146, 
    June 23, 1998). We note that, to date, we have not issued any duty 
    absorption findings in this case.
        In its substantive response, Rhodia argued that the Department, 
    consistent with its Sunset Policy Bulletin, should provide the 
    Commission with the company-specific and all others rates from the 
    original investigation as the magnitude of the margin likely to prevail 
    if the order were revoked. Alternatively, Rhodia suggested that the 
    Department could conclude that higher margins would prevail if the 
    order were revoked. In this case, Rhodia suggests that, using Turkish 
    import and export statistics coupled with average U.S. import 
    statistics, the Department could calculate a new margin of 63.14 
    percent.
        Consistent with section II.B.1 of the Sunset Policy Bulletin, the 
    Department finds that the rates from the original investigation are 
    probative of the behavior of producers/exporters without the discipline 
    of the order. As a result, the Department determines, absent argument 
    and evidence to the contrary, that the margins from the original 
    investigation are the ones most likely to prevail if the order were 
    revoked. As such, we will report to the Commission the company-specific 
    and all others rates contained in the Final Results of Review section 
    of this notice.
    
    Final Results of Review
    
        As a result of this review, the Department finds that revocation of 
    the antidumping order would likely lead to continuation or recurrence 
    of dumping at the margins listed below:
    
    ------------------------------------------------------------------------
                                                                    Margin
                       Manufacturer/exporter                      (percent)
    ------------------------------------------------------------------------
    Atabay Kimya Sanayi ve Ticaret.............................        27.35
    Proces Kimya Sanayi ve Ticaret.............................        38.60
    All Others.................................................        32.98
    ------------------------------------------------------------------------
    
        This notice serves as the only reminder to parties subject to 
    administrative protective order (APO) of their responsibility 
    concerning the disposition of proprietary information disclosed under 
    APO in accordance with 19 CFR 351.305 of the Department's regulations. 
    Timely notification of return/destruction of APO materials or 
    conversion to judicial protective order is hereby requested. Failure to 
    comply with the regulations and the terms of an APO is a sanctionable 
    violation.
        This five-year (``sunset'') review and notice are in accordance 
    with sections 751(c), 752, and 777(i)(1) of the Act.
    
    Richard W. Moreland,
    Acting Assistant Secretary for Import Administration.
    [FR Doc. 99-17051 Filed 7-2-99; 8:45 am]
    BILLING CODE 3510-DS-P
    
    
    

Document Information

Effective Date:
7/6/1999
Published:
07/06/1999
Department:
International Trade Administration
Entry Type:
Notice
Action:
Notice of final results of expedited sunset review: aspirin from Turkey.
Document Number:
99-17051
Dates:
July 6, 1999.
Pages:
36328-36330 (3 pages)
Docket Numbers:
A-489-602
PDF File:
99-17051.pdf